Related Experiment Video
Updated: Aug 7, 2026
Biochemical Measurement of Neonatal Hypoxia
Published on: August 24, 2011
Heart rate variability in premature neonates pre-and postmethylxanthine administration
1Department of Anaesthesia, Waikato Hospital, Hamilton, New Zealand.
Insights
Methylxanthines, used for infant respiratory issues, significantly improved heart rate variability (HRV) in premature infants. This suggests methylxanthines may normalize autonomic function, mirroring normal infant development.
Area of Science:
- Neonatal Medicine
- Pharmacology
- Autonomic Neuroscience
Background:
- Methylxanthines are crucial for managing respiratory failure in premature infants.
- Heart rate variability (HRV) is a key indicator of autonomic nervous system function.
- Assessing the impact of methylxanthines on autonomic function in neonates is important.
Purpose of the Study:
- To investigate the effects of methylxanthine administration on HRV in premature infants.
- To compare HRV indices before and after methylxanthine dosing.
Main Methods:
- Studied 22 premature infants (24-36 weeks gestational age).
- Measured various HRV indices pre- and post-methylxanthine administration.
- Utilized ANOVA for statistical analysis of HRV changes.
Main Results:
- Significant increase in overall HRV observed post-methylxanthine dosing (P = 0.001).
- A notable increase in the high-frequency (HF) band of HRV was recorded.
- The positive effect on HRV was more pronounced in critically ill infants.
Conclusions:
- Methylxanthine administration enhances HRV in premature infants.
- The observed HRV pattern suggests methylxanthines may normalize autonomic function.
- These findings indicate a potential therapeutic role for methylxanthines in promoting autonomic maturation.
Abstract:
Methylxanthines are used to treat or prevent respiratory failure (apnoea) in premature infants both perinatally and perioperatively. Heart rate variability (HRV) is being increasingly used to measure autonomic function. In this study various indices of HRV were compared pre- and postmethylxanthine dosing in 22 infants (aged 24-36 weeks). HRV significantly increased postdosing, particularly in the high frequency (HF) band (P = 0.001 by ANOVA). This increase was more pronounced in the sickest infants. This pattern of increased HRV and %HF is the same that occurs with normal maturation. This suggests that methylxanthine may stimulate and normalize autonomic function.
